What is Xeris Biopharma Holdings, Inc.'s revenue?

Xeris Biopharma Holdings, Inc. (XERS) reported revenue of $83.13M in Q1 2026.

How has Xeris Biopharma Holdings, Inc.'s revenue changed year-over-year?

Xeris Biopharma Holdings, Inc.'s revenue increased by 38.3% year-over-year, from $60.12M to $83.13M.

What is the long-term trend for Xeris Biopharma Holdings, Inc.'s revenue?

Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s revenue has grown at a 55.9% compound annual growth rate (CAGR), from $49.45M to $291.85M.

Xeris Biopharma Holdings, Inc. XERS Revenue

Revenue at other companies

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

Ollie's Bargain Outlet Holdings, Inc.OLLI

$658.93M+14.2%

PhotronicsPLAB

$209.94M-0.5%

First BanCorpFBP

$258.64M+4.2%

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+76.9%

Enterprise value$1.42B+52.7%

P/E106.4×—

P/S4.1×+0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s revenue?: Xeris Biopharma Holdings, Inc. (XERS) reported revenue of $83.13M in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s revenue changed year-over-year?: Xeris Biopharma Holdings, Inc.'s revenue increased by 38.3% year-over-year, from $60.12M to $83.13M.
What is the long-term trend for Xeris Biopharma Holdings, Inc.'s revenue?: Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s revenue has grown at a 55.9% compound annual growth rate (CAGR), from $49.45M to $291.85M.